Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 4
Results: 36
Rituximab-pvvr is not an independent predictor for infusion reactions in a cohort given rituximab-pvvr or rituximab: A single-center retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 892, doi. 10.1177/10781552221080710
- By:
- Publication type:
- Article
Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 898, doi. 10.1177/10781552221080078
- By:
- Publication type:
- Article
Investigating Potential Drug-Drug Interactions in Pediatric and Adolescent Patients Receiving Chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 904, doi. 10.1177/10781552221079786
- By:
- Publication type:
- Article
Retrospective drug utilization review of meropenem and role of infectious disease pharmacist in specialized cancer care hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 910, doi. 10.1177/10781552221077929
- By:
- Publication type:
- Article
Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 916, doi. 10.1177/10781552221077254
- By:
- Publication type:
- Article
Veliparib for the treatment of solid malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 924, doi. 10.1177/10781552221073990
- By:
- Publication type:
- Article
Lichen planopilaris-like eruption in chronic myeloid leukemia patient during treatment with nilotinib as second-line therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 969, doi. 10.1177/10781552211073957
- By:
- Publication type:
- Article
Oral oncolytic treatment for chronic lymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 935, doi. 10.1177/10781552211073906
- By:
- Publication type:
- Article
Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 972, doi. 10.1177/10781552211073885
- By:
- Publication type:
- Article
Azacitidine-induced massive pericardial effusion in a child with myelodysplastic syndrome.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 975, doi. 10.1177/10781552211073884
- By:
- Publication type:
- Article
Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 979, doi. 10.1177/10781552211073883
- By:
- Publication type:
- Article
Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 983, doi. 10.1177/10781552211073881
- By:
- Publication type:
- Article
Ado-trastuzumab emtansine associated spider telangiectasia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 986, doi. 10.1177/10781552211073878
- By:
- Publication type:
- Article
Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 989, doi. 10.1177/10781552211073823
- By:
- Publication type:
- Article
Skin toxicity after Filgrastim treatment for an Ewing's sarcoma patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 995, doi. 10.1177/10781552211073802
- By:
- Publication type:
- Article
Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 998, doi. 10.1177/10781552211073790
- By:
- Publication type:
- Article
Biomarkers of everolimus efficacy in breast cancer therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 945, doi. 10.1177/10781552211073673
- By:
- Publication type:
- Article
Necrotizing leg gangrene from invasive cutaneous Kaposi sarcoma, reversed by pegylated liposomal doxorubicin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 1003, doi. 10.1177/10781552211073532
- By:
- Publication type:
- Article
Severe Generalized Weakness, Paraplegia following administration of Oxaliplatin in a patient with refractory T-cell non-Hodgkin lymphoma: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 1009, doi. 10.1177/10781552211073531
- By:
- Publication type:
- Article
Hydroxyurea- a cost effective treatment in developing countries for Atypical Chronic Myeloid Leukemia (aCML): Case Report of Two Patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 1014, doi. 10.1177/10781552211073518
- By:
- Publication type:
- Article
The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 960, doi. 10.1177/10781552211073517
- By:
- Publication type:
- Article
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 1019, doi. 10.1177/10781552211073345
- By:
- Publication type:
- Article
Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 771, doi. 10.1177/10781552211017634
- By:
- Publication type:
- Article
Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 777, doi. 10.1177/10781552211012059
- By:
- Publication type:
- Article
The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 785, doi. 10.1177/10781552211012038
- By:
- Publication type:
- Article
Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 794, doi. 10.1177/10781552211011221
- By:
- Publication type:
- Article
Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 805, doi. 10.1177/10781552211010928
- By:
- Publication type:
- Article
Retrospective review of accelerated daratumumab administration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 816, doi. 10.1177/10781552211009967
- By:
- Publication type:
- Article
Impact of anti-cancer drugs shortages in oncology and hematology departments in a Moroccan hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 822, doi. 10.1177/10781552211008212
- By:
- Publication type:
- Article
Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 827, doi. 10.1177/10781552211006182
- By:
- Publication type:
- Article
Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 836, doi. 10.1177/10781552211006180
- By:
- Publication type:
- Article
Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 842, doi. 10.1177/10781552211005529
- By:
- Publication type:
- Article
Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 850, doi. 10.1177/10781552211005525
- By:
- Publication type:
- Article
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 870, doi. 10.1177/10781552211005518
- By:
- Publication type:
- Article
Use of therapeutic outcomes monitoring method for performing of pharmaceutical care in oncology patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 884, doi. 10.1177/10781552211005072
- By:
- Publication type:
- Article